BOSTON SCIENTIFIC CLOSES ACQUISITION OF BTG PLC.

MARLBOROUGH, 19 August 2019

Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE:BTG) pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.

View the full press release